Blog
Androgen deprivation therapy for prostate cancer – an often forgotten risk factor for osteoporosis
Prostate cancer is the most common male solid organ malignancy. Almost half of the men with prostate cancer will be treated with androgen deprivation therapy...
Broadening the scope of osteoporosis intervention
Progressive bone mineral density (BMD) loss due to oestrogen deficiency in postmenopausal women is a key factor in ‘osteoporotic’ or ‘fragility’ fractures, with approximately 50...
Placing the spotlight on “bone health”: Osteoporosis Australia rebrands itself
Osteoporosis Australia recently announced its official rebrand to ‘Healthy Bones Australia’, to reinforce the importance of prevention, in response to the concerning 173,000 broken bones...
International Osteoporosis Foundation launches a new Policy toolkit to help shape health policies
The International Osteoporosis Foundation (IOF) has launched a comprehensive toolkit – the ‘Capture the Fracture® Partnership – Guidance for Policy Shaping’, comprising a step-by-step policy...
New benchmark set to deliver optimal osteoporosis care throughout Asia Pacific
Launch of first pan-Asia Pacific minimum clinical standards for the screening, diagnosis & management of osteoporosis The Asia Pacific Consortium on Osteoporosis (APCO) has...
A Tribute To A Legend In The Global Bone Arena
APCO mourns the passing of, and pays tribute to Professor Harry K Genant, a friend, respected colleague, and a true legend in the bone field....
Hip fractures – Avoiding the black hole of missed management opportunities
Dr Nigel Gilchrist, Canterbury District Health Board, Christchurch, New Zealand and APCO Executive Committee Member Hip fractures in old adults are common, affecting up to...
Cost-effective fracture-probability based intervention thresholds for osteoporosis – one size does not fit all countries
The number of individuals at risk for fragility fractures worldwide is predicted to increase two-fold from the 158 million it was in 2010, to 319...
